[1]
Ozodbekova, U. 2026. GLP-1-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence, Cardiorenal Benefits, Safety and Future Directions. Bulletin of Contemporary Researches. 2, 4 (Nov. 2026), 118–123.